Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients

By Lerbæk Anne   Kristiansen Thomas   Katzenstein Terese   Mathiesen Lars   Gerstoft Jan   Nielsen Claus   Larsen Klaus   Nielsen Jens   Obel Niels   Laursen Alex   Nielsen Susanne  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 4, 2004-04 ,pp. : 280-286

Informa Healthcare

Access to resources Recommend Favorite

Distinct Mutational Drug Resistance Profiles of HIV-1 RNA in Plasma and Culture Isolates of Patients Receiving Antiretroviral Therapy

By  

Intervirology, Vol. 45, Iss. 1, 2002-04 ,pp. : 52-55

Karger

Access to resources Recommend Favorite

The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran

By  

Intervirology, Vol. 60, Iss. 1-2, 2017-08 ,pp. : 33-37

Karger

Access to resources Recommend Favorite

Use of almotriptan in triptan-experienced and triptan-naïve patients

By Pascual Julio   Diener Hans-Christoph  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2433-2440

Informa Healthcare

Access to resources Recommend Favorite

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite